Individual and synergistic cytokine effects controlling the expansion of cord blood CD34⁺ cells and megakaryocyte progenitors in culture

References

• Brunstein CG, Setubal DC, Wagner JE. Expanding the role of umbilical cord blood transplantation. Br J Haematol. 2007;137:20–35.
   Google Scholar
• Boiron JM, Dazey B, Cailliot C, Launay B, Attal M, Mazurier F, . Large-scale expansion and transplantation of CD34(+) hematopoietic cells: in vitro and in vivo confirmation of neutropenia abrogation related to the expansion process without impairment of the long-term engraftment capacity. Transfusion. 2006;46:1934–42.
   Google Scholar
• Prince HM, Simmons PJ, Whitty G, Wall DP, Barber L, Toner GC, . Improved haematopoietic recovery following transplantation with ex vivo-expanded mobilized blood cells. Br J Haematol. 2004;126:536–45.
   PubMed Web of Science ®Google Scholar
• Decaudin D, Vantelon JM, Bourhis JH, Farace F, Bonnet ML, Guillier M, . Ex vivo expansion of megakaryocyte precursor cells in autologous stem cell transplantation for relapsed malignant lymphoma. Bone Marrow Transplant. 2004;34: 1089–93.
   PubMed Web of Science ®Google Scholar
• Rocha V, Labopin M, Sanz G, Arcese W, Schwerdtfeger R, Bosi A, . Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia. N Engl J Med. 2004;351:2276–85.
   PubMed Web of Science ®Google Scholar
• Jaroscak J, Goltry K, Smith A, Waters-Pick B, Martin PL, Driscoll TA, . Augmentation of umbilical cord blood (UCB) transplantation with ex vivo-expanded UCB cells: results of a phase 1 trial using the AastromReplicell System. Blood. 2003;101:5061–7.
   PubMed Web of Science ®Google Scholar
• Shpall EJ, Quinones R, Giller R, Zeng C, Baron AE, Jones RB, . Transplantation of ex vivo expanded cord blood. Biol Blood Marrow Transplant. 2002;8:368–76.
   PubMed Web of Science ®Google Scholar
• Datta NS, Williams JL, Caldwell J, Curry AM, Ashcraft EK, Long MW. Novel alterations in CDK1/cyclin B1 kinase complex formation occur during the acquisition of a polyploid DNA content. Mol Biol Cell. 1996;7:209–23.
   PubMedGoogle Scholar
• Bertolini F, Battaglia M, Pedrazzoli P, Da Prada GA, Lanza A, Soligo D, . Megakaryocytic progenitors can be generated ex vivo and safely administered to autologous peripheral blood progenitor cell transplant recipients. Blood. 1997;89: 2679–88.
   PubMed Web of Science ®Google Scholar
• Williams JL, Pipia GG, Datta NS, Long MW. Thrombopoietin requires additional megakaryocyte-active cytokines for optimal ex vivo expansion of megakaryocyte precursor cells. Blood. 1998;91:4118–26.
   PubMed Web of Science ®Google Scholar
• van den Oudenrijn S, von dem Borne AE, de Haas M. Differences in megakaryocyte expansion potential between CD34(+) stem cells derived from cord blood, peripheral blood, and bone marrow from adults and children. Exp Hematol. 2000;28:1054–61.
   PubMed Web of Science ®Google Scholar
• Shaw PH, Gilligan D, Wang XM, Thall PF, Corey SJ. Ex vivo expansion of megakaryocyte precursors from umbilical cord blood CD34 cells in a closed liquid culture system. Biol Blood Marrow Transplant. 2003;9:151–6.
   Google Scholar
• Petzer AL, Zandstra PW, Piret JM, Eaves CJ. Differential cytokine effects on primitive (CD34+CD38−) human hematopoietic cells: novel responses to Flt3-ligand and thrombopoietin. J Exp Med. 1996;183:2551–8.
   PubMed Web of Science ®Google Scholar
• Zandstra PW, Conneally E, Petzer AL, Piret JM, Eaves CJ. Cytokine manipulation of primitive human hematopoietic cell self-renewal. Proc Natl Acad Sci USA. 1997;94:4698–703.
   PubMed Web of Science ®Google Scholar
• Audet J, Miller CL, Eaves CJ, Piret JM. Common and distinct features of cytokine effects on hematopoietic stem and progenitor cells revealed by dose–response surface analysis. Biotechnol Bioeng. 2002;80:393–404.
   PubMed Web of Science ®Google Scholar
• Fujiki H, Kimura T, Minamiguchi H, Harada S, Wang J, Nakao M, . Role of human interleukin-9 as a megakaryocyte potentiator in culture. Exp Hematol. 2002;30:1373–80.
   PubMed Web of Science ®Google Scholar
• Baksh D, Davies JE, Zandstra PW. Soluble factor cross-talk between human bone marrow-derived hematopoietic and mesenchymal cells enhances in vitro CFU-F and CFU-O growth and reveals heterogeneity in the mesenchymal progenitor cell compartment. Blood. 2005;106:3012–9.
   PubMed Web of Science ®Google Scholar
• Cortin V, Garnier A, Pineault N, Lemieux R, Boyer L, Proulx C. Efficient in vitro megakaryocyte maturation using cytokine cocktails optimized by statistical experimental design. Exp Hematol. 2005;33:1182–91.
   PubMed Web of Science ®Google Scholar
• Wang W, Horner DN, Chen WL, Zandstra PW, Audet J. Synergy between erythropoietin and stem cell factor during erythropoiesis can be quantitatively described without co-signaling effects. Biotechnol Bioeng. 2008;99:1261–72.
   Google Scholar
• Chen TW, Hwang SM, Chu IM, Hsu SC, Hsieh TB, Yao CL. Characterization and transplantation of induced megakaryocytes from hematopoietic stem cells for rapid platelet recovery by a two-step serum-free procedure. Exp Hematol. 2009;37: 1330–39.
   PubMedGoogle Scholar
• Lotem J, Sachs L. Cytokine control of developmental programs in normal hematopoiesis and leukemia. Oncogene. 2002;21:3284–94.
   PubMed Web of Science ®Google Scholar
• Boyer L, Robert A, Proulx C, Pineault N. Increased production of megakaryocytes near purity from cord blood CD34+ cells using a short two-phase culture system. J Immunol Methods. 2008;332:82–91.
   PubMed Web of Science ®Google Scholar
• Proulx C, Boyer L, Hurnanen DR, Lemieux R. Preferential ex vivo expansion of megakaryocytes from human cord blood CD34+-enriched cells in the presence of thrombopoietin and limiting amounts of stem cell factor and Flt-3 ligand. J Hematother Stem Cell Res. 2003;12:179–88.
   PubMedGoogle Scholar
• Proulx C, Dupuis N, St-Amour I, Boyer L, Lemieux R. Increased megakaryopoiesis in cultures of CD34-enriched cord blood cells maintained at 39 degrees C. Biotechnol Bioeng. 2004;88:675–80.
   PubMed Web of Science ®Google Scholar
• Pineault N, Boucher J-F, Cayer M-P, Palmqvist L, Boyer L, Lemieux R, . Characterization of the effects and potential mechanisms leading to increased megakaryocytic differentiation under mild hyperthermia. Stem Cells Dev. 2008;17:483–94.
   Google Scholar
• Box GEP, Hunter WG, Hunter JS. Box GEP, Hunter WG, Hunter JS. Statistics for Experimenters: An Introduction to Design, Data Analysis and Model Building. New York: John Wiley & Sons; 1978.
   Google Scholar
• Zeigler FC, de Sauvage F, Widmer HR, Keller GA, Donahue C, Schreiber RD, . In vitro megakaryocytopoietic and thrombopoietic activity of c-mpl ligand (TPO) on purified murine hematopoietic stem cells. Blood. 1994;84:4045–52.
   PubMed Web of Science ®Google Scholar
• de Sauvage FJ, Hass PE, Spencer SD, Malloy BE, Gurney AL, Spencer SA, . Stimulation of megakaryocytopoiesis and thrombopoiesis by the c-Mpl ligand. Nature. 1994; 369:533–8.
   PubMed Web of Science ®Google Scholar
• Schipper LF, Brand A, Reniers NC, Melief CJ, Willemze R, Fibbe WE. Effects of thrombopoietin on the proliferation and differentiation of primitive and mature haemopoietic progenitor cells in cord blood. Br J Haematol. 1998;101:425–35.
   Google Scholar
• Dolzhanskiy A, Basch RS, Karpatkin S. The development of human megakaryocytes. III. Development of mature megakaryocytes from highly purified committed progenitors in synthetic culture media and inhibition of thrombopoietin-induced polyploidization by interleukin-3. Blood. 1997;89: 426–34.
   PubMed Web of Science ®Google Scholar
• Schattner M, Lefebvre P, Mingolelli SS, Goolsby CL, Rademaker A, White JG, . Thrombopoietin-stimulated ex vivo expansion of human bone marrow megakaryocytes. Stem Cells. 1996;14:207–14.
   Google Scholar
• De Bruyn C, Delforge A, Martiat P, Bron D. Ex vivo expansion of megakaryocyte progenitor cells: cord blood versus mobilized peripheral blood. Stem Cells Dev. 2005;14:415–24.
   PubMed Web of Science ®Google Scholar
• Feng Y, Zhang L, Xiao ZJ, Li B, Liu B, Fan CG, . An effective and simple expansion system for megakaryocyte progenitor cells using a combination of heparin with thrombopoietin and interleukin-11. Exp Hematol. 2005;33:1537–43.
   PubMed Web of Science ®Google Scholar
• Matsunaga T, Tanaka I, Kobune M, Kawano Y, Tanaka M, Kuribayashi K, . Ex vivo large-scale generation of human platelets from cord blood CD34+ cells. Stem Cells. 2006; 24:2877–87.
   PubMed Web of Science ®Google Scholar
• Sigurjonsson OE, Gudmundsson KO, Haraldsdottir V, Rafnar T, Agnarsson BA, Gudmundsson S. Flt3/Flk-2 ligand in combination with thrombopoietin decreases apoptosis in megakaryocyte development. Stem Cells Dev. 2004;13: 183–91.
   PubMed Web of Science ®Google Scholar
• Ueda T, Tsuji K, Yoshino H, Ebihara Y, Yagasaki H, Hisakawa H, . Expansion of human NOD/SCID-repopulating cells by stem cell factor, Flk2/Flt3 ligand, thrombopoietin, IL-6, and soluble IL-6 receptor. J Clin Invest. 2000; 105:1013–21.
   PubMed Web of Science ®Google Scholar
• Rollini P, Kaiser S, Faes-van't Hull E, Kapp U, Leyvraz S. Long-term expansion of transplantable human fetal liver hematopoietic stem cells. Blood. 2004;103:1166–70.
   Google Scholar
• Kollet O, Aviram R, Chebath J, Ben-Hur H, Nagler A, Shultz L, . The soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro maintenance and proliferation of human CD34(+)CD38(–/low) cells capable of repopulating severe combined immunodeficiency mice. Blood. 1999;94: 923–31.
   PubMed Web of Science ®Google Scholar
• Broudy VC. Stem cell factor and hematopoiesis. Blood. 1997;90:1345–64.
   PubMed Web of Science ®Google Scholar
• Papayannopoulou T, Brice M, Farrer D, Kaushansky K. Insights into the cellular mechanisms of erythropoietin–thrombopoietin synergy. Exp Hematol. 1996;24:660–9.
   PubMed Web of Science ®Google Scholar
• Salles, II, Thijs T, Brunaud C, De Meyer SF, Thys J, Vanhoorelbeke K, . Human platelets produced in nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice upon transplantation of human cord blood CD34(+) cells are functionally active in an ex vivo flow model of thrombosis. Blood. 2009;114:5044–51.
   Google Scholar
• Passegue E, Wagers AJ, Giuriato S, Anderson WC, Weissman IL. Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates. J Exp Med. 2005;202:1599–611.
   PubMed Web of Science ®Google Scholar
• Glimm H, Oh IH, Eaves CJ. Human hematopoietic stem cells stimulated to proliferate in vitro lose engraftment potential during their S/G(2)/M transit and do not reenter G(0). Blood. 2000;96:4185–93.
   PubMed Web of Science ®Google Scholar
• Luens KM, Travis MA, Chen BP, Hill BL, Scollay R, Murray LJ. Thrombopoietin, kit ligand, and flk2/flt3 ligand together induce increased numbers of primitive hematopoietic progenitors from human CD34+Thy-1+Lin− cells with preserved ability to engraft SCID-hu bone. Blood. 1998; 91:1206–15.
   PubMed Web of Science ®Google Scholar
• Ramsfjell V, Bryder D, Bjorgvinsdottir H, Kornfalt S, Nilsson L, Borge OJ, . Distinct requirements for optimal growth and in vitro expansion of human CD34(+)CD38(−) bone marrow long-term culture-initiating cells (LTC-IC), extended LTC-IC, and murine in vivo long-term reconstituting stem cells. Blood. 1999;94:4093–102.
   Google Scholar
• Mattia G, Milazzo L, Vulcano F, Pascuccio M, Macioce G, Hassan HJ, . Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture. Exp Hematol. 2008;36:244–52.
   PubMedGoogle Scholar
• van Hensbergen Y, Schipper LF, Brand A, Slot MC, Welling M, Nauta AJ, . Ex vivo culture of human CD34+ cord blood cells with thrombopoietin (TPO) accelerates platelet engraftment in a NOD/SCID mouse model. Exp Hematol. 2006;34:943–50.
   PubMedGoogle Scholar
• Tijssen MR, van Hennik PB, di Summa F, Zwaginga JJ, van der Schoot CE, Voermans C. Transplantation of human peripheral blood CD34-positive cells in combination with ex vivo generated megakaryocytes results in fast platelet formation in NOD/SCID mice. Leukemia. 2008;22: 203–8.
   PubMed Web of Science ®Google Scholar
• Bruno S, Gunetti M, Gammaitoni L, Perissinotto E, Caione L, Sanavio F, . Fast but durable megakaryocyte repopulation and platelet production in NOD/SCID mice transplanted with ex-vivo expanded human cord blood CD34+ cells. Stem Cells. 2004;22:135–43.
   PubMed Web of Science ®Google Scholar
• Angelopoulou M, Novelli E, Grove JE, Rinder HM, Civin C, Cheng L, . Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice. Exp Hematol. 2003;31:413–20.
   PubMed Web of Science ®Google Scholar
• Kaufman RM, Airo R, Pollack S, Crosby WH. Circulating megakaryocytes and platelet release in the lung. Blood. 1965;26:720–31.
   PubMed Web of Science ®Google Scholar
• Stenberg PE, Levin J. Mechanisms of platelet production. Blood Cells. 1989;15:23–47.
   PubMedGoogle Scholar
• Delaney C, Heimfeld S, Brashem-Stein C, Voorhies H, Manger RL, Bernstein ID. Notch-mediated expansion of human cord blood progenitor cells capable of rapid myeloid reconstitution. Nat Med. 2010;16:232–6.
   PubMed Web of Science ®Google Scholar